Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01058226 · ClinicalTrials.gov registry record · Phase 1
Reproducibility of Malaria Challenge in Healthy Volunteers
A Phase 1 study, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT01058226: Completed Phase 1 study, sponsored by Seattle Children's Hospital.
NCT01058226 is a Phase 1 study that has completed, run by Seattle Children's Hospital. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01058226, a Phase 1 study, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the well-established malaria challenge model at the Seattle Biomedical Research Institute (Seattle BioMed).
Interventions
- BIOLOGICAL Malaria challenge (wild-type NF54 strain Plasmodium falciparum sporozoites)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-09 |
| Phase | Phase 1 |
What the finished NCT01058226 record still lists
NCT01058226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Malaria challenge (wild-type NF54 strain Plasmodium falciparum sporozoites) is the first listed.
NCT01058226 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01058226 about?
NCT01058226 is a clinical study titled "Reproducibility of Malaria Challenge in Healthy Volunteers". This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the well-established malaria challenge model at the Seattle Biomedical Research Institute (Seattle BioMed).
What is the current status of trial NCT01058226?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2010-02. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01058226?
The interventions under investigation include: Malaria challenge (wild-type NF54 strain Plasmodium falciparum sporozoites) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01058226?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01058226's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia